72 related articles for article (PubMed ID: 9029495)
1. Full and partial agonists induce distinct desensitized states of the 5-HT3 receptor.
van Hooft JA; Vijverberg HP
J Recept Signal Transduct Res; 1997; 17(1-3):267-77. PubMed ID: 9029495
[TBL] [Abstract][Full Text] [Related]
2. Selection of distinct conformational states of the 5-HT3 receptor by full and partial agonists.
van Hooft JA; Vijverberg HP
Br J Pharmacol; 1996 Mar; 117(5):839-46. PubMed ID: 8851499
[TBL] [Abstract][Full Text] [Related]
3. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
4. Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors.
Hargreaves AC; Lummis SC; Taylor CW
Mol Pharmacol; 1994 Dec; 46(6):1120-8. PubMed ID: 7808432
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [3H]meta-chlorophenylbiguanide binding to 5-HT3 receptors in N1E-115 neuroblastoma cells.
Lummis SC; Sepúlveda MI; Kilpatrick GJ; Baker J
Eur J Pharmacol; 1993 Oct; 243(1):7-11. PubMed ID: 8253126
[TBL] [Abstract][Full Text] [Related]
6. Biguanide derivatives: agonist pharmacology at 5-hydroxytryptamine type 3 receptors in vitro.
Morain P; Abraham C; Portevin B; De Nanteuil G
Mol Pharmacol; 1994 Oct; 46(4):732-42. PubMed ID: 7969053
[TBL] [Abstract][Full Text] [Related]
7. The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.
Suryanarayanan A; Joshi PR; Bikádi Z; Mani M; Kulkarni TR; Gaines C; Schulte MK
Biochemistry; 2005 Jun; 44(25):9140-9. PubMed ID: 15966738
[TBL] [Abstract][Full Text] [Related]
8. Facilitatory actions of serotonin type 3 receptors on GABAergic inhibitory synaptic transmission in the spinal superficial dorsal horn.
Fukushima T; Ohtsubo T; Tsuda M; Yanagawa Y; Hori Y
J Neurophysiol; 2009 Sep; 102(3):1459-71. PubMed ID: 19369358
[TBL] [Abstract][Full Text] [Related]
9. Different efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment.
Niemeyer MI; Lummis SC
Br J Pharmacol; 1998 Feb; 123(4):661-6. PubMed ID: 9517385
[TBL] [Abstract][Full Text] [Related]
10. The agonist properties of m-chlorophenylbiguanide and 2-methyl-5-hydroxytryptamine on 5-HT3 receptors in N1E-115 neuroblastoma cells.
Sepúlveda MI; Lummis SC; Martin IL
Br J Pharmacol; 1991 Oct; 104(2):536-40. PubMed ID: 1797317
[TBL] [Abstract][Full Text] [Related]
11. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats.
Higgins GA; Joharchi N; Sellers EM
J Pharmacol Exp Ther; 1993 Mar; 264(3):1440-9. PubMed ID: 8450478
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of NMDA-receptor mediated response in the rat medial prefrontal cortical pyramidal cells by the 5-HT3 receptor agonist SR 57227A and 5-HT: intracellular studies.
Liang X; Arvanov VL; Wang RY
Synapse; 1998 Jul; 29(3):257-68. PubMed ID: 9635896
[TBL] [Abstract][Full Text] [Related]
14. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog.
Jensen TN; Nielsen J; Frederiksen K; Ebert B
Eur J Pharmacol; 2006 May; 538(1-3):23-31. PubMed ID: 16647053
[TBL] [Abstract][Full Text] [Related]
16. Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine(3A) receptor.
Machu TK; Hamilton ME; Frye TF; Shanklin CL; Harris MC; Sun H; Tenner TE; Soti FS; Kem WR
J Pharmacol Exp Ther; 2001 Dec; 299(3):1112-9. PubMed ID: 11714901
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells.
Bartrup JT; Newberry NR
J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):679-90. PubMed ID: 8683467
[TBL] [Abstract][Full Text] [Related]
18. 5-HT3 receptors in NG108-15 neuroblastoma x glioma cells: effect of the novel agonist 1-(m-chlorophenyl)-biguanide.
Boess FG; Sepúlveda MI; Lummis SC; Martin IL
Neuropharmacology; 1992 Jun; 31(6):561-4. PubMed ID: 1407396
[TBL] [Abstract][Full Text] [Related]
19. 5-hydroxytryptamine3 (5-HT3) receptors mediate spinal 5-HT antinociception: an antisense approach.
Paul D; Yao D; Zhu P; Minor LD; Garcia MM
J Pharmacol Exp Ther; 2001 Aug; 298(2):674-8. PubMed ID: 11454930
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.
Unsworth CD; Molinoff PB
J Pharmacol Exp Ther; 1994 Apr; 269(1):246-55. PubMed ID: 8169832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
